Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
64
CL Quote, Financials, Valuation and Earnings
Last price:
$80.29
Seasonality move
:
3.6%
Day range:
$79.70 - $80.40
52-week range:
$74.55 - $100.18
Dividend yield:
2.57%
P/E ratio:
22.49x
P/S ratio:
3.25x
P/B ratio:
75.57x
Volume:
1.9M
Avg. volume:
6.2M
1-year change:
-13.14%
Market cap:
$64.7B
Revenue:
$20.1B
EPS (TTM):
$3.57
Analysts' Opinion
-
Consensus RatingColgate-Palmolive Co. has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 7 Buy ratings, 7 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $87.32, Colgate-Palmolive Co. has an estimated upside of 8.81% from its current price of $80.25.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $77.00 representing 100% downside risk from its current price of $80.25.
Fair Value
-
According to the consensus of 15 analysts, Colgate-Palmolive Co. has 8.81% upside to fair value with a price target of $87.32 per share.
CL vs. S&P 500
-
Over the past 5 trading days, Colgate-Palmolive Co. has underperformed the S&P 500 by -0.76% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Colgate-Palmolive Co. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Colgate-Palmolive Co. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Colgate-Palmolive Co. reported revenues of $5.1B.
Earnings Growth
-
Colgate-Palmolive Co. has grown year-over-year earnings for 9 quarters straight. In the most recent quarter Colgate-Palmolive Co. reported earnings per share of $0.91.
Enterprise value:
72B
EV / Invested capital:
7.46x
Price / LTM sales:
3.25x
EV / EBIT:
16.40x
EV / Revenue:
3.58x
PEG ratio (5yr expected):
8.86x
EV / Free cash flow:
20.92x
Price / Operating cash flow:
18.99x
Enterprise value / EBITDA:
14.41x
Gross Profit (TTM):
$12.1B
Return On Assets:
18.02%
Net Income Margin (TTM):
15.15%
Return On Equity:
345.67%
Return On Invested Capital:
32.52%
Operating Margin:
21.38%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $19.1B | $20.1B | $20.1B | $5B | $5.1B | |
| Gross Profit | $11B | $12.1B | $12.1B | $3.1B | $3B | |
| Operating Income | $4B | $4.6B | $4.4B | $1.1B | $1.1B | |
| EBITDA | $4.5B | $5.2B | $5B | $1.3B | $1.3B | |
| Diluted EPS | $1.91 | $3.48 | $3.57 | $0.90 | $0.91 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.7B | $5.3B | $5.4B | $5.8B | $6B | |
| Total Assets | $15.9B | $16.3B | $16B | $16.8B | $17.5B | |
| Current Liabilities | $4.3B | $4.5B | $4.6B | $5.6B | $6.5B | |
| Total Liabilities | $14.9B | $15.2B | $15.6B | $15.9B | $16.3B | |
| Total Equity | $1B | $1.1B | $406M | $836M | $1.2B | |
| Total Debt | $7.7B | $8.2B | $8.7B | $7.9B | $8.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $3.3B | $4B | $4B | $1.2B | $1.3B | |
| Cash From Investing | -$772M | -$597M | -$794M | -$150M | -$154M | |
| Cash From Financing | -$2.5B | -$3.1B | -$3.2B | -$904M | -$1B | |
| Free Cash Flow | $2.6B | $3.4B | $3.4B | $1B | $1.1B | |
CL
Sector
Market Cap
$64.7B
$125M
Price % of 52-Week High
80.11%
70.73%
Dividend Yield
2.57%
0%
Shareholder Yield
4.42%
2.3%
1-Year Price Total Return
-13.14%
-7.05%
Beta (5-Year)
0.299
0.255
Dividend yield:
2.57%
Annualized payout:
$1.98
Payout ratio:
57.32%
Growth streak:
35 years
Technicals
8-day SMA
Buy
Level
$79.18
200-day SMA
Sell
Level
$85.47
Bollinger Bands (100)
Sell
Level
77.44 - 83.28
Chaikin Money Flow
Buy
Level
2.1B
20-day SMA
Buy
Level
$78.65
Relative Strength Index (RSI14)
Buy
Level
56.95
ADX Line
Buy
Level
11.84
Williams %R
Sell
Level
-3.4489
50-day SMA
Buy
Level
$78.38
MACD (12, 26)
Buy
Level
0.23
25-day Aroon Oscillator
Sell
Level
-40
On Balance Volume
Neutral
Level
2B
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (7.2613)
Sell
CA Score
(Annual)
Level (-0.9394)
Buy
Beneish M-Score
(Annual)
Level (-2.9289)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (1.3795)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care, and Pet Nutrition segments. The Oral, Personal, and Home Care segment includes toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. The Pet Nutrition segment offers specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.
Stock Forecast FAQ
In the current month, CL has received 7 Buy ratings 7 Hold ratings, and 1 Sell ratings. The CL average analyst price target in the past 3 months is $87.32.
-
Where Will Colgate-Palmolive Co. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Colgate-Palmolive Co. share price will rise to $87.32 per share over the next 12 months.
-
What Do Analysts Say About Colgate-Palmolive Co.?
Analysts are divided on their view about Colgate-Palmolive Co. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Colgate-Palmolive Co. is a Sell and believe this share price will drop from its current level to $77.00.
-
What Is Colgate-Palmolive Co.'s Price Target?
The price target for Colgate-Palmolive Co. over the next 1-year time period is forecast to be $87.32 according to 15 Wall Street analysts, 7 of them rate the stock a Buy, 1 rates the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is CL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Colgate-Palmolive Co. is a Leans Bullish. 7 of 15 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of CL?
You can purchase shares of Colgate-Palmolive Co. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Colgate-Palmolive Co. shares.
-
What Is The Colgate-Palmolive Co. Share Price Today?
Colgate-Palmolive Co. was last trading at $80.29 per share. This represents the most recent stock quote for Colgate-Palmolive Co.. Yesterday, Colgate-Palmolive Co. closed at $80.25 per share.
-
How To Buy Colgate-Palmolive Co. Stock Online?
In order to purchase Colgate-Palmolive Co. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get CL Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CL
Sector
P/E ratio
22.49x
16.73x
PEG ratio
8.86x
0.13x
P/B ratio
75.57x
1.49x
Price / LTM sales
3.25x
0.51x
Growth Metrics
CL
Sector
Revenue growth
1.95%
2.99%
Earnings growth
1.25%
5%
Revenue (5-year growth)
5.08%
3.31%
Earnings forecast
$0.89
$0.32
Profitability
CL
Sector
Profitability FY 2024
$12.1B
$263.1M
Return on invested capital
32.52%
4.37%
Return on assets
18.02%
3.04%
Return on equity
345.67%
7.5%
Earnings Date
Last Earnings Date
Oct
31
Next Earnings Date
Jan
30
Estimated Next Earnings Date
Jan
30
Balance Sheet
CL
Sector
Total cash
$1.5B
$87.3M
Short term investments
--
$32.9M
Total assets
$16B
$1.1B
Long term debt
$8.4B
$6.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
